EUVIMEDEUVIMED entdecken
Crossref

Seasonal Impact on Grade ≥2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis

Dirk Rades, Stefan Janssen, Carlos A Narvaez-Wolf, Charlotte Kristiansen, Carmen Timke, Marciana N Duma, Tobias Bartscht, Nathan Y Yu

Anticancer Research · 2024

DOI: 10.21873/anticanres.17067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Dirk Rades und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de. Hauptthemen laut MEDLINE: Breast Neoplasms, Seasons, Radiodermatitis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: We investigated grade ≥2 dermatitis in patients irradiated for breast cancer. This study evaluated associations between dermatitis and the season during which radiotherapy took place. PATIENTS AND METHODS: Associations between the season and grade ≥2 dermatitis were retrospectively evaluated in 327 breast cancer patients. Seasons were March to May (spring), June to August (summer), September to November (autumn), and December to February (winter). Subgroup analyses were performed considering fractionation, radiation technique, treatment volume, radiation boost, and deep-inspiration breath-hold technique. Furthermore, warmer and cooler months were compared. RESULTS: The season had no significant impact on the rate of grade ≥2 dermatitis in the entire cohort (p=0.63) nor in the subgroup analyses (p-values between 0.17 and 0.82). No significant difference in rate was found between warm and cool months. CONCLUSION: Grade ≥2 dermatitis was not associated with the season during which radiotherapy was performed. This factor may not be important for stratification in prospective trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSeasonsRadiodermatitisHumansFemaleMiddle AgedAgedRetrospective StudiesAdultAged, 80 and over

Stichwörter der Autor:innen

Breast canceradjuvant irradiationgrade ≥2 radiation dermatitisseason of treatment

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
  • Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany.
  • Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.
  • Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Odense, Denmark.
  • Department of Radiotherapy, Malteser Hospital St. Franziskus, Flensburg, Germany.
  • Department for Human Medicine, MSH Medical School Hamburg, Hamburg, Germany.

Zitieren

APA

Rades, D., Janssen, S., Narvaez-Wolf, C. A., Kristiansen, C., Timke, C., Duma, M. N., Bartscht, T., & Yu, N. Y. (2024). Seasonal Impact on Grade ≥2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis. Anticancer Research. https://doi.org/10.21873/anticanres.17067

Vancouver

Rades D, Janssen S, Narvaez-Wolf CA, Kristiansen C, Timke C, Duma MN, et al. Seasonal Impact on Grade ≥2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis. Anticancer Research. 2024. doi:10.21873/anticanres.17067

BibTeX
@article{Rades2024,
  author = {Rades, Dirk and Janssen, Stefan and Narvaez-Wolf, Carlos A and Kristiansen, Charlotte and Timke, Carmen and Duma, Marciana N and Bartscht, Tobias and Yu, Nathan Y},
  title = {Seasonal Impact on Grade ≥2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17067}
}
Kostenlos starten →